Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 22, 1993 - Issue 4
12
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Irreversible Suppression of CD8 Expression in CD4-CD8+ Thymocytes Upon in vitro Stimulation

, , &
Pages 301-318 | Published online: 07 Jul 2009
 

Abstract

CD8 (Ly-2) expression was suppressed in purified murine CD4-CD8+ thymocytes at the mRNA level upon continuous stimulation with PMA and ionomycin in the presence of rIL-2. The level of CD8 expression on CD4CD8+ thymocytes was reduced gradually during the culture and a majority of them turned into CD4 CD8 cells after 48 hr. This suppression was not transient, since CD8 expression was not recovered on these cells in additional 48 hr of culture without PMA and ionomycin. The suppression was dependent on the concentrations of PMA and ionomycin, and inhibited by adding an immunosuppressant, CsA to the culture. Treatment with either PMA or ionomycin alone did not induce suppression of CD8. Crosslinking of CD3-ϵ chains also induced suppression of CD8 for a part of CD4CD8+ thymocytes. Interestingly, CD8 expression was hardly suppressed in CD4CD8+ peripheral T lymphocytes, suggesting that the mechanisms of suppression of CD8 is developmentally regulated. We propose that the suppression of CD8 expression at CD4CD8+ stage involves an additional mechanism of negative selection of thymic T cells.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.